Bacteria and spontaneous experimental colitis: Immunological changes

European Journal of Clinical Investigation

Volumn 41, Issue 10, 2011, Pages 1047-1053

  Pedrosa, Elisabet ^a,b   Lorén, Violeta ^a,b   Cabré, Eduard ^b,c   Doménech, Eugeni ^b,c   Ojanguren, Isabel ^c   Gassull, Miquel A ^a   Mañé, Josep ^a,b  

^a Health Sciences Research Institute   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Apoptosis; Environment; Experimental colitis; IL 10( ) mice; Lymphocytes; Toll like receptors

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL ASSESSMENT; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BACTERIA; COLITIS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9;

EID: 80052619579     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02499.x     Document Type: Article

References (24)

1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-40.
2. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 2006;3:275-84.
3. Wells RW, Blennerhassett MG. The increasing prevalence of Crohn's disease in industrialized societies: the price of progress?. Can J Gastroenterol 2005;19:89-95.
4. Hugot JP, Alberti C, Berrebi D, Bingen E, Cezard JP. Crohn's disease: the cold chain hypothesis. Lancet 2003;362:2012-5.
5. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
6. West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, Ljunggren HG et al. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 2004;305:1153-7.
7. Cario E, Podolsky DK. Intestinal epithelial TOLLerance versus inTOLLerance of commensals. Mol Immunol 2004;42:887-93.
8. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998;161:5733-44.
9. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
10. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31.
11. Kennedy RJ, Hoper M, Deodhar K, Erwin PJ, Kirk SJ, Gardiner KR. Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. Br J Surg 2000;87:1346-51.
12. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice. Gastroenterology 1999;116:1107-14.
13. Mañé J, Pedrosa E, Lorén V, Ojanguren I, Fluvià L, Cabré E et al. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10 deficient mice. J Nutr 2009;139:603-10.
14. Ye J, Lee JW, Presley LL, Bent E, Wei B, Braun J et al. Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice. Inflamm Bowel Dis 2008;14:1041-50.
15. Nüssler NC, Stange B, Hoffman RA, Schraut WH, Bauer AJ, Neuhaus P. Enhanced cytolytic activity of intestinal intraepithelial lymphocytes in patients with Crohn's disease. Langenbecks Arch Surg 2000;385:218-24.
16. Chen Y, Chou K, Fuchs E, Havran WL, Boismenu R. Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA 2002;99:14338-43.
17. Smith TR, Kumar V. Revival of CD8+ Treg-mediated suppression. Trends Immunol 2008;29:337-42.
18. Brimnes J, Allez M, Dotan I, Shao L, Nakazawa A, Mayer L. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol 2005;174:5814-22.
19. von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008;321:691-6.
20. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010-7.
21. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007;132:1359-74.
22. Arrieta MC, Madsen K, Doyle J, Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 2009;58:41-8.
23. Moreira LO, El Kasmi KC, Smith AM, Finkelstein D, Fillon S, Kim YG et al. The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls. Cell Microbiol 2008;10:2067-77.
24. Cario E. Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword. Inflamm Bowel Dis 2008;14:411-21.